These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The role of group II metabotropic glutamate receptors in hippocampal CA1 long-term potentiation in vitro.
    Author: Behnisch T, Wilsch VW, Balschun D, Reymann KG.
    Journal: Eur J Pharmacol; 1998 Sep 04; 356(2-3):159-65. PubMed ID: 9774245.
    Abstract:
    The role of group II metabotropic glutamate receptors (mGlu receptors) in mechanisms of long-term potentiation was investigated by analysis of excitatory postsynaptic field potentials of the CA1 region in rat hippocampal slices. The application of the group II agonists (2S,1'S,2'S)-2-(carboxycyclopropyl) glycine (L-CCG-I) and (2S,1'R,2'R,3'R)-2-(2',3'-dicarboxycyclopropyl) glycine (DCG IV) resulted in a dose-dependent reduction of long term potentiation in the concentration range 3-50 microM. In contrast to the effects of group II agonists on long-term potentiation, the group II antagonists (RS)-alpha-methyl-3-carboxy-4-hydroxy-phenylglycine (M3C4HPG) and (RS)-alpha-methylserine-O-phosphate monophenyl ester (MSOPPE) elicited a dose-dependent enhancement of long-term potentiation (50-100 microM or 20-50 microM, respectively). We conclude that group II mGlu receptors are not essential for the induction of long-term potentiation; however, they may be involved in feedback mechanisms in long-term potentiation.
    [Abstract] [Full Text] [Related] [New Search]